SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $418,000 | +45.6% | 3,780 | -1.1% | 0.05% | +50.0% |
Q2 2022 | $287,000 | -61.4% | 3,823 | -59.8% | 0.03% | -57.0% |
Q1 2022 | $743,000 | +118.5% | 9,511 | +151.6% | 0.08% | +113.5% |
Q4 2021 | $340,000 | -63.3% | 3,780 | -62.3% | 0.04% | -65.1% |
Q3 2021 | $927,000 | +165.6% | 10,021 | +123.0% | 0.11% | +178.9% |
Q2 2021 | $349,000 | +1.7% | 4,493 | -2.3% | 0.04% | -7.3% |
Q1 2021 | $343,000 | -85.5% | 4,599 | -66.9% | 0.04% | -88.3% |
Q4 2020 | $2,367,000 | +47.4% | 13,886 | +21.4% | 0.35% | +29.7% |
Q3 2020 | $1,606,000 | -23.6% | 11,439 | -12.7% | 0.27% | -25.9% |
Q2 2020 | $2,101,000 | +158.1% | 13,102 | +57.4% | 0.36% | +132.7% |
Q1 2020 | $814,000 | -5.0% | 8,323 | +25.3% | 0.16% | +27.9% |
Q4 2019 | $857,000 | +242.8% | 6,640 | +100.1% | 0.12% | +205.0% |
Q3 2019 | $250,000 | -77.8% | 3,318 | -55.2% | 0.04% | -77.9% |
Q2 2019 | $1,124,000 | +231.6% | 7,400 | +160.4% | 0.18% | +212.1% |
Q1 2019 | $339,000 | – | 2,842 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,315,000 | $170,397,700 | 13.20% |
EcoR1 Capital, LLC | 2,999,453 | $388,669,120 | 11.83% |
Evolutionary Tree Capital Management, LLC | 63,756 | $8,261,502 | 7.93% |
Tri Locum Partners LP | 119,695 | $15,510,000 | 6.27% |
Avoro Capital Advisors LLC | 3,175,000 | $411,416,500 | 6.15% |
Camber Capital Management LP | 1,250,000 | $161,975 | 5.56% |
Finepoint Capital LP | 131,457 | $17,034 | 5.51% |
ACUTA CAPITAL PARTNERS, LLC | 67,500 | $8,746,650 | 5.38% |
Logos Global Management LP | 220,000 | $28,507,600 | 3.34% |
AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 33,454 | $3,401,657 | 3.20% |